Glycostem Therapeutics B.V is a startup based in the Netherlands, 2 tracked investors.
Glycostem Therapeutics B.V is a startup based in the Netherlands. Brouky records 2 investors associated with the company.
Glycostem Therapeutics develops allogeneic off-the-shelf Natural Killer (NK) cell therapies derived from umbilical cord blood stem cells to treat various cancers including acute myeloid leukemia and multiple myeloma.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.